Ogawa, T <br/><br/>
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Feb 2007 
 - 347-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2006.01647.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amides--pharmacology<br/>Animals<br/>Carcinoma, Hepatocellular--physiopathology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Disease Models, Animal<br/>Enzyme Inhibitors--pharmacology<br/>Immunosuppressive Agents--pharmacology<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Liver Neoplasms, Experimental--physiopathology<br/>Liver Transplantation<br/>Male<br/>Neoplasm Invasiveness--physiopathology<br/>Neoplasm Recurrence, Local--physiopathology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Pyridines--pharmacology<br/>Rats<br/>Rats, Inbred BUF<br/>Signal Transduction--drug effects<br/>Tacrolimus--pharmacology<br/>rho-Associated Kinases